Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| CLD4 | O14493 | Claudin-4 (Clostridium perfringens enterotoxin receptor) (CPE-R) (CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein) | Cancer-related genesDisease related genesHuman disease related genes | 4 | Williams-Beuren syndrome | Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation | 17 | 0.72 | ||
| ICAM3 | P32942 | Intercellular adhesion molecule 3 (ICAM-3) (CDw50) (ICAM-R) (CD antigen CD50) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Immune mediation | 17 | 0.72 | |||
| KCNN4 | O15554 | Intermediate conductance calcium-activated potassium channel protein 4 (SKCa 4) (SKCa4) (hSK4) (Gardos channel) (IKCa1) (hIK1) (KCa3.1) (Putative Gardos channel) (hKCa4) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | Hereditary hemolytic anemiaAlzheimer diseaseChronic pain | Clinical-translation mediationFusion and delivery mediationImmune mediation | 17 | 0.72 | ||
| CBPD | O75976 | Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 16 | 0.72 | |||
| ITM2B | Q9Y287 | Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)] | Disease related genesHuman disease related genesPotential drug targets | 1 | AmyloidosisDeafness | Fusion and delivery mediationMetabolism mediation | 16 | 0.72 | ||
| CD82 | P27701 | CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82) | Cancer-related genesCD markersPlasma proteins | 4 | Clinical-translation mediationFusion and delivery mediation | 14 | 0.72 | |||
| DRB4 | P13762 | HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4) | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 14 | 0.72 | ||||
| EMP3 | P54852 | Epithelial membrane protein 3 (EMP-3) (Hematopoietic neural membrane protein 1) (HNMP-1) (Protein YMP) | 4 | Other mediation | 13 | 0.72 | ||||
| LIRB3 | O75022 | Leukocyte immunoglobulin-like receptor subfamily B member 3 (LIR-3) (Leukocyte immunoglobulin-like receptor 3) (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5) (ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a) | 1 | Fusion and delivery mediationImmune mediation | 13 | 0.72 | ||||
| MRP4 | O15439 | ATP-binding cassette sub-family C member 4 (EC 7.6.2.-) (EC 7.6.2.2) (EC 7.6.2.3) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B) (Multidrug resistance-associated protein 4) | EnzymesMetabolic proteinsPlasma proteins | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 13 | 0.72 |